Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.
Author: Rebecca Robbins
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says